Does caffeine interfere with lisdexamfetamine (Vyvanse)?

Caffeine and Vyvanse: No Clinically Significant Interference

Caffeine does not meaningfully interfere with lisdexamfetamine (Vyvanse) pharmacologically, though combining two stimulants may additively increase cardiovascular effects and side effects like anxiety, insomnia, and jitteriness.

Pharmacokinetic Evidence

The FDA label for Vyvanse explicitly states that neither food nor orange juice affects the absorption or blood levels (AUC and Cmax) of dextroamphetamine after lisdexamfetamine administration 1. While caffeine is not specifically mentioned in the drug label, a formal drug interaction study demonstrated that lisdexamfetamine does not alter the metabolism of caffeine (a CYP1A2 substrate), with geometric mean ratios for caffeine exposure remaining within bioequivalence ranges 2. This bidirectional lack of pharmacokinetic interaction means neither substance changes how the other is absorbed, metabolized, or eliminated from the body.

Lisdexamfetamine is converted to dextroamphetamine primarily through red blood cell hydrolysis, not through cytochrome P450 enzymes 1. Since caffeine is metabolized by CYP1A2, there is no shared metabolic pathway that would create competition or interference.

Pharmacodynamic Considerations

Both caffeine and amphetamines are CNS stimulants, but they work through different mechanisms:

• Lisdexamfetamine/dextroamphetamine: Blocks reuptake and increases release of norepinephrine and dopamine 1
• Caffeine: Primarily acts as an adenosine receptor antagonist, with secondary effects on dopamine

Additive Stimulant Effects

The main concern is additive stimulation rather than true interference. Animal studies show complex interactions:

• Caffeine can produce cross-tolerance to some amphetamine-like effects, particularly those mediated by dopamine D1 receptors 3
• Paradoxically, caffeine may attenuate some amphetamine-induced hyperactivity in certain contexts 4
• At therapeutic doses in hyperactive children, caffeine and amphetamine can be used together, though high caffeine doses (600 mg/day) produced side effects 5

Clinical Management Algorithm

For patients taking Vyvanse who consume caffeine:

1. Monitor total stimulant load: Limit caffeine to <300 mg/day (per ACC/AHA hypertension guidelines for patients on amphetamines) 6, 7, 8

2. Watch for additive side effects:

   • Increased heart rate and blood pressure
   • Anxiety, jitteriness, restlessness
   • Insomnia (avoid caffeine after 4:00 PM per palliative care guidelines) 9
   • Decreased appetite

3. Special populations requiring lower caffeine limits:

   • Children/adolescents: <2.5 mg/kg/day caffeine 10
   • Patients with uncontrolled hypertension: avoid caffeine entirely 6, 7, 8
   • Pregnant women: <200 mg/day caffeine 10

4. Timing considerations: Since Vyvanse reaches peak levels 3.5-4.4 hours after dosing 1, spacing caffeine intake away from this peak may reduce additive cardiovascular effects

Key Caveats

• The ACC/AHA guidelines specifically list amphetamines as medications that can elevate blood pressure, recommending dose reduction or discontinuation when possible 6, 7, 8. Adding caffeine increases this cardiovascular burden.

• While moderate caffeine (180-200 mg/day) typically provides alertness benefits with low risk of adverse effects 10, patients on Vyvanse already have CNS stimulation and may experience side effects at lower caffeine doses than the general population.

• There is no evidence that caffeine reduces Vyvanse effectiveness—the concern is purely about additive side effects, not therapeutic interference.